Blood Biomarker Test Granted Breakthrough Device Status by FDA
Quanterix’s ultra-sensitive blood test that measures a biomarker of nerve damage in people with multiple sclerosis (MS) has been…
Articles by Lindsey Shapiro, PhD
Kesimpta Now Reimbursable for Patients in 2 Canadian Provinces
Kesimpta (ofatumumab) is now accessible to eligible Canadians with relapsing-remitting multiple sclerosis (RRMS) through public drug plans in…
In Relapsing MS, NfL Levels Help in Disease Progression Prediction
Serum levels of neurofilament light chain (NfL) — proteins found in nerve cell projections — can help in the prediction…
Chinese Authorities Approve Trial of SN1011; US Study on Horizon
The National Medical Products Administration (NMPA) of China has agreed to approve a Phase 2 trial testing the safety and…
MSTOP Program in California Cuts DMT Costs and MS Relapse Rates
A program aimed at optimizing the use of highly effective therapies successfully lowered treatment costs and relapse rates among people…
Gray Matter Loss in Spine Crucial, But Difficult, Marker of MS Disability
Loss of gray matter in the spinal cord clearly associates with greater disability in people with multiple sclerosis (MS),…
Long-term Gilenya Use Safe, Effective in Real-world Czech Study
Treatment with Gilenya (fingolimod) for up to four years was found safe and lowered relapse rates among people with…
Active Social Life Linked to Better Physical, Psychological Health
Greater engagement in social activities and positive social support were associated with better physical and psychological health among people with…
$1M Invested in Study on Effects of Childhood-onset MS Over Time
About CA$1.35 million ($1.07 million) has been invested in a project that seeks to understand the effects of multiple sclerosis…
MS Patients May Meet Criteria for Sjögren’s Diagnosis, Study Reports
Symptoms of Sjögren’s syndrome, including dry eyes and mouth, were observed among 16 people with multiple sclerosis (MS),…
Irisin Hormone May Underlie Benefits of Aerobic Exercise for RRMS
Six weeks of aerobic exercise led to benefits in cognition, fatigue, and depression among people with relapsing-remitting multiple sclerosis…
Use of GA Depot in Treating Progressive MS Given US Patent
Mapi Pharma announced that it has been granted a U.S. patent covering the use of GA Depot, a…
Rexall’s Bubble Campaign Supports Caregiver Initiatives
Rexall Care Network, a nonprofit organization that is part of the Rexall Pharmacy Group, has launched a campaign to…
Trial Cleared for PIPE-307, Potential RRMS Myelin Restoration Therapy
The U.S. Food and Drug Administration (FDA) has cleared a Phase 1b/2a trial of PIPE-307, Pipeline Therapeutics‘ investigational myelin-restoring…
Hormone Therapy May Help With Menopause, But Safety a Concern
Eight weeks of hormone therapy was tolerable, and its use may ease the hot flashes and greater disease-related disability this…
No Increased Risk Found From Ocrevus Exposure in Pregnancy
Exposure to Ocrevus (ocrelizumab) just before conception or during the first three months of pregnancy does not seem to…
Online Mindfulness Program Helps Patients With Depression, Trial Finds
Eight weeks of an online mindfulness program significantly lowered levels of depression and improved quality of life in people with…
BDNF Risk Variant Linked to Brain Inflammation in New RRMS Patients
A risk variant in the BDNF gene is tied to increased brain inflammation and reduced cortical thickness on MRI scans…
MS Patients Voice Satisfaction With Telehealth Use During COVID-19
Telehealth services for physical and mental healthcare were used often by people with multiple sclerosis (MS) during the COVID-19…
Parents’ Aubagio Exposure Not Linked to Greater Pregnancy Risks
Maternal or paternal exposure prior to conception to the multiple sclerosis (MS) therapy Aubagio (teriflunomide) does…
MS Society, Corporate Partners Commit to Diversity in Clinical Trials
The National MS Society, together with a number of its corporate healthcare partners, want to help correct the lack of…
App Helps With Long-term Spasticity Management After Rehab
Multiple sclerosis (MS) patients who experience reductions in spasticity after a four-week course of inpatient rehabilitation can sustain…
UK MS Society Investing $1.5M in Support of 9 Research Projects
The MS Society of the U.K. intends to raise over £1.1 million (about $1.5 million) to support…
Neurodynamic Therapy Found to Reduce Pain, Improve Dexterity in Trial
The addition of neurodynamic therapy — a type of manual therapy targeting the nerves — to a standard treatment regimen…
Pasithea Plans to Develop Vaccine to Prevent Immune Attacks on Myelin
Pasithea Therapeutics announced plans to develop a tolerizing vaccine that would treat multiple sclerosis (MS) by…
Oligodendrocyte Gene Changes Evident Near MS Risk Mutations
Changes in the genome of oligodendrocytes were found in DNA regions associated with immune genes and risk mutations linked…
How Eating Meat Affects MS via Gut Microbiome, Immune Cells Detailed
A relationship between meat consumption and how it affects gut bacteria, immune cell profiles, and metabolism was identified in people…
Adverse Childhood Experiences Don’t Influence MS Risk: Study
Adverse childhood experiences (ACEs) did not increase the risk of multiple sclerosis (MS) development and were not associated with…
After Pregnancy, Women Show More Brain Lesions, Volume Loss
Women with relapsing-remitting multiple sclerosis (RRMS) have more brain lesions and accelerated brain volume loss (BVL) after pregnancy compared…
$600K Grant Supports Trial of Intervention to Improve Life Quality
A Kessler Foundation scientist has been awarded nearly $600,000 to support the development and testing of a behavioral…